Add to ORKGDo relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis g Xia
Glioblastoma (GB) is a highly aggressive brain tumor with dismal prognosis and its standard of care ...
BACKGROUND: Experimental data suggest that glioblastoma cells expressing the stem cell marker CD133 ...
Background Despite of a multimodal approach, recurrences can hardly be prevented in glioblastoma. T...
Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progr...
Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progr...
Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progr...
Despite improved knowledge and advanced treatments of high-grade gliomas, the overall survival rate ...
Cancer stem cells (CSC) are thought to represent the population of tumorigenic cells responsible for...
Despite improved knowledge and advanced treatments of high-grade gliomas, the overall survival rate ...
Purpose: Cancer stem cells (CSC) are thought to represent the population of tumorigenic cells respon...
Purpose: Cancer stem cells (CSC) are thought to represent the population of tumorigenic cells respon...
BackgroundCancer stem cells have been implicated in tumor relapse, tumor invasion, and cancer therap...
Background: Gliomas represent the most frequent primary tumors of central nervous system (CNS), cont...
Glioblastoma (GB) is a highly aggressive brain tumor with dismal prognosis and its standard of care ...
Glioblastoma (GB) is a highly aggressive brain tumor with dismal prognosis and its standard of care ...
Glioblastoma (GB) is a highly aggressive brain tumor with dismal prognosis and its standard of care ...
BACKGROUND: Experimental data suggest that glioblastoma cells expressing the stem cell marker CD133 ...
Background Despite of a multimodal approach, recurrences can hardly be prevented in glioblastoma. T...
Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progr...
Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progr...
Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progr...
Despite improved knowledge and advanced treatments of high-grade gliomas, the overall survival rate ...
Cancer stem cells (CSC) are thought to represent the population of tumorigenic cells responsible for...
Despite improved knowledge and advanced treatments of high-grade gliomas, the overall survival rate ...
Purpose: Cancer stem cells (CSC) are thought to represent the population of tumorigenic cells respon...
Purpose: Cancer stem cells (CSC) are thought to represent the population of tumorigenic cells respon...
BackgroundCancer stem cells have been implicated in tumor relapse, tumor invasion, and cancer therap...
Background: Gliomas represent the most frequent primary tumors of central nervous system (CNS), cont...
Glioblastoma (GB) is a highly aggressive brain tumor with dismal prognosis and its standard of care ...
Glioblastoma (GB) is a highly aggressive brain tumor with dismal prognosis and its standard of care ...
Glioblastoma (GB) is a highly aggressive brain tumor with dismal prognosis and its standard of care ...
BACKGROUND: Experimental data suggest that glioblastoma cells expressing the stem cell marker CD133 ...
Background Despite of a multimodal approach, recurrences can hardly be prevented in glioblastoma. T...